A Novel Apolipoprotein C-II Mimetic Peptide That Activates Lipoprotein Lipase and Decreases Serum Triglycerides in Apolipoprotein E–Knockout Mice

Apolipoprotein A-I (apoA-I) mimetic peptides are currently being developed as possible new agents for the treatment of cardiovascular disease based on their ability to promote cholesterol efflux and their other beneficial antiatherogenic properties. Many of these peptides, however, have been reporte...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Pharmacol Exp Ther
Päätekijät: Amar, Marcelo J. A., Sakurai, Toshihiro, Sakurai-Ikuta, Akiko, Sviridov, Denis, Freeman, Lita, Ahsan, Lusana, Remaley, Alan T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The American Society for Pharmacology and Experimental Therapeutics 2015
Aiheet:
Cardiovascular
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293430/
https://ncbi.nlm.nih.gov/pubmed/25395590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/jpet.114.220418
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia